Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910960 · ClinicalTrials.gov registry record · NA
Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02910960: Completed NA study, sponsored by AdventHealth.
NCT02910960 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02910960, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a randomized prospective clinical study comparing the Acquire Biopsy Device to SharkCore Biopsy Device.
Primary Outcome
The primary objective of this study is to compare the total area of procured tissue between the two FNB needles in patients undergoing EUS-guided sampling of pancreatic masses. Pancreatic masses sampled using the Acquire Endoscopic Ultrasound Fine Needle Biopsy Device needle should yield a tissue volume greater than the SharkCore Fine Needle Biopsy System needle because the serrated design of the FNB needle tip is expected to procure greater volume of tissue. This will be measured using a speci
Interventions
- DEVICE Acquire EUS Biopsy Device
- DEVICE SharkCore Biopsy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02910960 record still lists
NCT02910960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Acquire EUS Biopsy Device is the first listed.
NCT02910960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02910960 about?
NCT02910960 is a clinical study titled "Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses". This is a randomized prospective clinical study comparing the Acquire Biopsy Device to SharkCore Biopsy Device.
What is the current status of trial NCT02910960?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-12. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02910960?
The interventions under investigation include: Acquire EUS Biopsy Device (DEVICE), SharkCore Biopsy System (DEVICE).
Who is sponsoring clinical trial NCT02910960?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02910960's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia